Country: United Kingdom
Language: English
Source: HMA (Heads of Medicines Agencies)
alfaxalone 10 mg/ml
Jurox (UK) plc
QN01AX05
Solution for injection
alfaxalone
Cats, Dogs
2011-05-13
Revised: September 2013 AN: 00543/2013 Page 1 of 7 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Alfaxan 10 mg/ml solution for Injection for Dogs and Cats 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE SUBSTANCE: Alfaxalone 10 mg/ml For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for injection Clear colourless solution 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs and cats 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES As an induction agent prior to inhalation anaesthesia. As a sole anaesthetic agent for the induction and maintenance of anaesthesia for the performance of examination or surgical procedures. 4.3 CONTRAINDICATIONS Do not use in combination with other intravenous anaesthetic agents. 4.4 SPECIAL WARNINGS During recovery, it is preferable that animals are not handled or disturbed. This may lead to paddling, minor muscle twitching or movements that are more violent. While better avoided, such reactions are clinically insignificant. 4.5 SPECIAL PRECAUTIONS FOR USE (i) Special precautions for use in animals Appropriate analgesia should be provided in cases where procedures are anticipated to be painful. The safety of the veterinary medicinal product in animals less than 12 weeks of age has not been demonstrated. Transient post ind Read the complete document